Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T31048 |
CP-320626
CP 320626 |
||
CP-320626 is an effective inhibitor of glycogen phosphorylase A (LGPA) in the human liver and GPA in the human muscle. Can act synergistically with glucose. It is a possible target for the treatment of type 2 diabetes. |